Welcome to My Blog

Here is a masonry blog layout with no sidebar

COVID-19 testing, treatment free for Ayushman Bharat beneficiaries at pvt labs, empanelled hosps

“Testing and treatment of COVID-19 is already available for free in public facilities. Now, more than 50 crore citizens, eligible under the health assurance scheme will be able to avail free testing through private labs and treatment for COVID-19 in empanelled hospitals,” it said in a statement.

IRDAI asks insurers to follow rules strictly in paying commissions to the intermediaries  

The board approved policy should stipulate the specific proportion of rewards to commission/remuneration which sholud be reasonable and justifiable, to individual insurance agent/insurance intermediary subject to the overall limit as specified in the existing regulations-Reg 6(d)(ii) and 6(e)(ii) of IRDAI (Payment of commission or remuneration or reward to insurance agents and insurance intermediaries) Regulations, 2016.

Why is New Orleans’ coronavirus death rate twice New York’s? Obesity is a factor

New Orleans residents suffer from obesity, diabetes and hypertension at rates higher than the national average, conditions that doctors and public health officials say can make patients more vulnerable to COVID-19, the highly contagious respiratory disease caused by the coronavirus.

Some 97% of those killed by COVID-19 in Louisiana had a pre-existing condition, according to the state health department. Diabetes was seen in 40% of the deaths, obesity in 25%, chronic kidney disease in 23% and cardiac problems in 21%.

29 insurers launch new standard health products, to cover Covid-19 treatment costs

Besides newly launched ‘Arogya Sanjeevani’ IRDAI has already clarified to the public, that the existing indemnity based health insurance products, that cover the treatment costs of hospitalization offered by all general and health insurance companies,also cover the costs of hospitalization treatment on account of COVID -19.

Insurers fret as company bosses face coronavirus legal claims

“An uptick in litigation targeting directors and officers across industry sectors is one likely, and unwelcome, consequence” of the coronavirus pandemic, said James Whitaker, partner at law firm Mayer Brown.

“We are starting to see insurers looking at the potential for specific COVID-19 exclusions going forward,” said Beth Thurston, head of management liability, UK & Ireland, for broker Marsh.